NASDAQ:SVOK

Seven Oaks Acquisition Competitors

$9.88
-0.01 (-0.10 %)
(As of 06/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.86
$9.88
50-Day Range
$9.65
$9.92
52-Week Range
$9.56
$10.96
Volume73,191 shs
Average Volume251,798 shs
Market Capitalization$277.88 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Seven Oaks Acquisition (NASDAQ:SVOK) Vs. CPUH, BCSF, TBA, CRHC, APSG, and BROG

Should you be buying SVOK stock or one of its competitors? Companies in the industry of "holding & other investment offices" are considered alternatives and competitors to Seven Oaks Acquisition, including Compute Health Acquisition (CPUH), Bain Capital Specialty Finance (BCSF), Thoma Bravo Advantage (TBA), Cohn Robbins (CRHC), Apollo Strategic Growth Capital (APSG), and Brooge Energy (BROG).

Compute Health Acquisition (NYSE:CPUH) and Seven Oaks Acquisition (NASDAQ:SVOK) are both small-cap unclassified companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Valuation and Earnings

This table compares Compute Health Acquisition and Seven Oaks Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Compute Health AcquisitionN/AN/AN/AN/AN/A
Seven Oaks AcquisitionN/AN/A$-4,220,000.00N/AN/A

Insider & Institutional Ownership

56.5% of Compute Health Acquisition shares are owned by institutional investors. Comparatively, 69.1% of Seven Oaks Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Compute Health Acquisition and Seven Oaks Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Compute Health Acquisition0000N/A
Seven Oaks Acquisition0000N/A

Profitability

This table compares Compute Health Acquisition and Seven Oaks Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Compute Health AcquisitionN/AN/AN/A
Seven Oaks AcquisitionN/AN/AN/A

Summary

Seven Oaks Acquisition beats Compute Health Acquisition on 1 of the 1 factors compared between the two stocks.

Bain Capital Specialty Finance (NYSE:BCSF) and Seven Oaks Acquisition (NASDAQ:SVOK) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Valuation and Earnings

This table compares Bain Capital Specialty Finance and Seven Oaks Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bain Capital Specialty Finance$194.46 million5.27$8.28 million$1.4610.86
Seven Oaks AcquisitionN/AN/A$-4,220,000.00N/AN/A

Bain Capital Specialty Finance has higher revenue and earnings than Seven Oaks Acquisition.

Insider & Institutional Ownership

51.9% of Bain Capital Specialty Finance shares are owned by institutional investors. Comparatively, 69.1% of Seven Oaks Acquisition shares are owned by institutional investors. 0.5% of Bain Capital Specialty Finance shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Bain Capital Specialty Finance and Seven Oaks Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bain Capital Specialty Finance03002.00
Seven Oaks Acquisition0000N/A

Bain Capital Specialty Finance presently has a consensus target price of $12.6667, indicating a potential downside of 20.13%. Given Bain Capital Specialty Finance's higher probable upside, equities analysts plainly believe Bain Capital Specialty Finance is more favorable than Seven Oaks Acquisition.

Profitability

This table compares Bain Capital Specialty Finance and Seven Oaks Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bain Capital Specialty Finance74.93%8.11%3.31%
Seven Oaks AcquisitionN/AN/AN/A

Summary

Bain Capital Specialty Finance beats Seven Oaks Acquisition on 7 of the 8 factors compared between the two stocks.

Thoma Bravo Advantage (NYSE:TBA) and Seven Oaks Acquisition (NASDAQ:SVOK) are both small-cap unclassified companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Valuation and Earnings

This table compares Thoma Bravo Advantage and Seven Oaks Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thoma Bravo AdvantageN/AN/A$-30,000.00N/AN/A
Seven Oaks AcquisitionN/AN/A$-4,220,000.00N/AN/A

Insider & Institutional Ownership

83.2% of Thoma Bravo Advantage shares are owned by institutional investors. Comparatively, 69.1% of Seven Oaks Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Thoma Bravo Advantage and Seven Oaks Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Thoma Bravo Advantage0000N/A
Seven Oaks Acquisition0000N/A

Profitability

This table compares Thoma Bravo Advantage and Seven Oaks Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Thoma Bravo AdvantageN/AN/AN/A
Seven Oaks AcquisitionN/AN/AN/A

Summary

Thoma Bravo Advantage beats Seven Oaks Acquisition on 2 of the 2 factors compared between the two stocks.

Cohn Robbins (NYSE:CRHC) and Seven Oaks Acquisition (NASDAQ:SVOK) are both small-cap unclassified companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Valuation and Earnings

This table compares Cohn Robbins and Seven Oaks Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cohn RobbinsN/AN/A$-250,000.00N/AN/A
Seven Oaks AcquisitionN/AN/A$-4,220,000.00N/AN/A

Insider & Institutional Ownership

57.1% of Cohn Robbins shares are owned by institutional investors. Comparatively, 69.1% of Seven Oaks Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Cohn Robbins and Seven Oaks Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cohn Robbins0000N/A
Seven Oaks Acquisition0000N/A

Profitability

This table compares Cohn Robbins and Seven Oaks Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cohn RobbinsN/AN/AN/A
Seven Oaks AcquisitionN/AN/AN/A

Apollo Strategic Growth Capital (NYSE:APSG) and Seven Oaks Acquisition (NASDAQ:SVOK) are both small-cap unclassified companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Valuation & Earnings

This table compares Apollo Strategic Growth Capital and Seven Oaks Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollo Strategic Growth CapitalN/AN/A$-410,000.00N/AN/A
Seven Oaks AcquisitionN/AN/A$-4,220,000.00N/AN/A

Insider and Institutional Ownership

60.2% of Apollo Strategic Growth Capital shares are owned by institutional investors. Comparatively, 69.1% of Seven Oaks Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Apollo Strategic Growth Capital and Seven Oaks Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Apollo Strategic Growth Capital0000N/A
Seven Oaks Acquisition0000N/A

Profitability

This table compares Apollo Strategic Growth Capital and Seven Oaks Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Apollo Strategic Growth CapitalN/AN/AN/A
Seven Oaks AcquisitionN/AN/AN/A

Brooge Energy (NASDAQ:BROG) and Seven Oaks Acquisition (NASDAQ:SVOK) are both small-cap utilities companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Valuation & Earnings

This table compares Brooge Energy and Seven Oaks Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brooge Energy$44.08 million22.50$-76,560,000.00N/AN/A
Seven Oaks AcquisitionN/AN/A$-4,220,000.00N/AN/A

Seven Oaks Acquisition has lower revenue, but higher earnings than Brooge Energy.

Insider and Institutional Ownership

3.0% of Brooge Energy shares are owned by institutional investors. Comparatively, 69.1% of Seven Oaks Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Brooge Energy and Seven Oaks Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Brooge Energy00103.00
Seven Oaks Acquisition0000N/A

Given Brooge Energy's higher probable upside, research analysts clearly believe Brooge Energy is more favorable than Seven Oaks Acquisition.

Profitability

This table compares Brooge Energy and Seven Oaks Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Brooge EnergyN/AN/AN/A
Seven Oaks AcquisitionN/AN/AN/A

Summary

Brooge Energy beats Seven Oaks Acquisition on 3 of the 5 factors compared between the two stocks.


Seven Oaks Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CPUH
Compute Health Acquisition
0.2$9.75-0.0%$1.05 billionN/A0.00
Bain Capital Specialty Finance logo
BCSF
Bain Capital Specialty Finance
1.6$15.86-0.3%$1.02 billion$194.46 million6.90
TBA
Thoma Bravo Advantage
0.3$9.98-0.0%$1.02 billionN/A0.00
CRHC
Cohn Robbins
0.2$9.81-0.2%$1.02 billionN/A0.00
APSG
Apollo Strategic Growth Capital
0.2$9.78-0.1%$998.55 millionN/A0.00
Brooge Energy logo
BROG
Brooge Energy
0.8$9.05-0.9%$991.77 million$44.08 million0.00Upcoming Earnings
GSAH
GS Acquisition Holdings Corp II
0.6$10.07-0.2%$944.06 million$70,000.000.00News Coverage
CONX
CONX
0.2$9.88-0.0%$926.45 millionN/A0.00
PNTM
Pontem
0.2$9.72-0.2%$838.35 millionN/A0.00
PRPB
CC Neuberger Principal Holdings II
0.3$9.86-0.2%$816.41 millionN/A0.00
FVIV
Fortress Value Acquisition Corp. IV
0.0$9.85-0.5%$800.31 millionN/A0.00News Coverage
AVAN
Avanti Acquisition
0.2$9.73-0.0%$729.75 millionN/A0.00
AGC
Altimeter Growth
0.0$11.71-0.3%$728.95 millionN/A0.00
MSDA
MSD Acquisition
0.0$9.86-0.3%$708.69 millionN/A0.00News Coverage
RBAC
RedBall Acquisition
0.2$9.77-0.2%$702.22 millionN/A0.00
FPAC
Far Peak Acquisition
0.2$9.92-2.0%$691.92 millionN/A0.00
GRSV
Gores Holdings V
0.3$10.40-0.1%$682.50 millionN/A0.00
Horizon Acquisition logo
HZAC
Horizon Acquisition
0.2$10.00-0.1%$679.98 millionN/A0.00News Coverage
CCVI
Churchill Capital Corp VI
0.0$9.81-0.3%$676.89 millionN/A0.00
SPAQ
SPARTAN Acquisition CORP. III
0.8$9.80-0.2%$676.20 millionN/A0.00
WPCB
Warburg Pincus Capital Co. I-B
0.0$9.84-0.3%$674.97 millionN/A0.00News Coverage
Global Cord Blood logo
CO
Global Cord Blood
0.8$5.36-2.4%$651.51 million$172.50 million9.40Upcoming Earnings
News Coverage
VYGG
Vy Global Growth
0.2$9.96-0.1%$638.93 millionN/A0.00
TREB
Trebia Acquisition
0.3$9.82-0.1%$635.24 millionN/A0.00
CCV
Churchill Capital Corp V
0.2$10.11-0.9%$631.88 millionN/A0.00
LCA
Landcadia Holdings IV
0.0$9.74-0.2%$608.75 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.65-0.2%$603.13 millionN/A0.00
ETAC
E.Merge Technology Acquisition
0.3$9.76-0.2%$597.31 millionN/A0.00
IPOD
Social Capital Hedosophia Holdings Corp. IV
0.0$10.31-0.3%$592.83 millionN/A0.00News Coverage
JBI
Janus International Group
0.3$13.43-1.0%$579.17 millionN/A0.00News Coverage
REVH
Revolution Healthcare Acquisition
0.0$9.92-0.0%$572.88 millionN/A0.00News Coverage
SEAH
Sports Entertainment Acquisition
0.2$10.12-0.1%$569.25 millionN/A0.00Unusual Options Activity
News Coverage
JIH
Juniper Industrial
0.3$13.19-0.0%$568.82 millionN/A0.00
GOAC
GO Acquisition
0.3$9.80-0.3%$563.50 millionN/A0.00
HAAC
Health Assurance Acquisition
0.2$10.05-0.2%$556.52 millionN/A0.00
CCAP
Crescent Capital BDC
1.5$19.32-0.4%$544.19 million$77.11 million3.60High Trading Volume
PRPC
CC Neuberger Principal Holdings III
0.0$9.77-0.6%$540.41 millionN/A0.00
ARVL
Arrival
1.4$16.57-2.7%$535.92 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.2$12.08-1.0%$528.50 millionN/A0.00News Coverage
FMAC
FirstMark Horizon Acquisition
0.2$9.94-0.5%$514.40 millionN/A0.00
TBCP
Thunder Bridge Capital Partners III
0.0$9.75-0.1%$514.34 millionN/A0.00
EQD
Equity Distribution Acquisition
0.2$9.80-0.0%$507.15 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.2$9.77-0.8%$505.60 millionN/A0.00News Coverage
HHLA
HH&L Acquisition
0.0$9.75-0.3%$504.56 millionN/A0.00News Coverage
MOTV
Motive Capital
0.2$9.73-0.1%$503.53 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.2$9.73-0.0%$498.30 millionN/A0.00
DCRN
Decarbonization Plus Acquisition Co. II
0.0$9.86-0.0%$496.09 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.70-0.1%$495.79 millionN/A0.00
IIAC
Investindustrial Acquisition
0.2$9.82-0.0%$494.07 millionN/A0.00
NSTC
Northern Star Investment Corp. III
0.5$9.83-0.0%$492.31 millionN/A0.00
This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.